Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Receivables: 2019-2024

Historic Change in Receivables for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to $6.4 million.

  • LifeStance Health's Change in Receivables rose 714.29% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 10259.46%. This contributed to the annual value of $6.4 million for FY2024, which is 7353.88% down from last year.
  • LifeStance Health's Change in Receivables amounted to $6.4 million in FY2024, which was down 7353.88% from $24.2 million recorded in FY2023.
  • LifeStance Health's 5-year Change in Receivables high stood at $24.2 million for FY2021, and its period low was $6.4 million during FY2024.
  • In the last 4 years, LifeStance Health's Change in Receivables had a median value of $22.9 million in 2022 and averaged $19.1 million.
  • Per our database at Business Quant, LifeStance Health's Change in Receivables surged by 1159.58% in 2023 and then tumbled by 7353.88% in 2024.
  • Over the past 4 years, LifeStance Health's Change in Receivables (Annual) stood at $24.2 million in 2021, then fell by 10.53% to $21.7 million in 2022, then rose by 11.6% to $24.2 million in 2023, then plummeted by 73.54% to $6.4 million in 2024.
  • Its Change in Receivables stands at $6.4 million for FY2024, versus $24.2 million for FY2023 and $21.7 million for FY2022.